Two placebo-controlled monotherapy studies, one of 18- and one of 24-week duration, included patients treated with JANUVIA 100 mg daily, JANUVIA 200 mg daily, and placebo
Lower visceral and body fat Maintain or build skeletal muscle That combination improves metabolism, strength, energy, and longevity
In 2023 Lilly published results of its phase 2 trial for orforglipron, a once-daily oral drug which achieved up to 14.7% mean weight reduction at 36 weeks, and Pfizer has completed phase 2 trial for its oral drug danuglipron and is now optimising the formulation
The patients medical history, clinical management, and imaging results were carefully reviewed, ultimately leading to the diagnosis of vestibular neuritis
What Is Jennifer Hardy Jun 24 min read Oral Options: The Future of GLP-1s in a Pill The landscape of diabetes and obesity management made a significant transformation in 2026, driven by the development of oral glucagon-like peptide-1 (GLP-1) receptor agonists
